U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Sufentanil for Palliative Pain Relief: A Review of the Clinical Effectiveness, Cost-Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Nov 18.

Cover of Sufentanil for Palliative Pain Relief: A Review of the Clinical Effectiveness, Cost-Effectiveness and Guidelines

Sufentanil for Palliative Pain Relief: A Review of the Clinical Effectiveness, Cost-Effectiveness and Guidelines [Internet].

Show details

REFERENCES

1.
International Association for Hospice and Palliative Care (IAHPC). Essential medicines in palliative care: executive summary [Internet]. Houston (TX): World Health Organization; 2013. [cited 2015 Nov 10]. Available from: http://www​.who.int/selection_medicines​/committees​/expert/19/applications​/PalliativeCare_8_A_R.pdf.
2.
Wilson KG, Chochinov HM, Allard P, Chary S, Gagnon PR, Macmillan K, et al. Prevalence and correlates of pain in the Canadian National Palliative Care Survey. Pain Res Manag. 2009 Sep;14(5):365–370. Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC2779154. [PMC free article: PMC2779154] [PubMed: 19862371]
3.
Broglio K, Portenoy RK. UpToDate [Internet]. Waltham (MA): UpToDate; c2005. Pain assessment and management in the last weeks of life. 2015 Oct 23 [cited 2015 Nov 6] Available from: www​.uptodate.com Subscription required.
4.
Jackson V, Nabati L. [Internet]. Waltham (MA): UpToDate; c2005. Ethical considerations in effective pain management at the end of life. 2015 Oct 14 [cited 2015 Nov 6] Available from: www​.uptodate.com Subscription required.
5.
Cancer pain relief and palliative care. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1990;804:1–75. [cited 2015 Nov 11]; [PubMed: 1702248]
6.
Ontario drug benefit formulary/comparative drug index [Internet]. 42. Toronto (ON): Ministry of Health and Long-Term Care; Sep 30, 2015. [cited 2015 Nov 11]. Available from: http://www​.health.gov​.on.ca/en/pro/programs​/drugs/formulary42/edition_42.pdf.
7.
Cancer Care Ontario. Cancer Care Ontario's symptom management pocket guides: pain [Internet]. Toronto (ON): Cancer Care Ontario; 2010. [cited 2015 Nov 11]. Available from: https://www​.cancercare​.on.ca/CCO_DrugFormulary​/Pages/FileContent​.aspx?fileId=97479.
8.
Droney J, Levy J, Quigley C. Prescribing opioids in renal failure. J Opioid Manag. 2007 Nov;3(6):309–316. [PubMed: 18290582]
9.
UpToDate [Internet]. Waltham (MA): UpToDate; c2005. Sufentanil: drug information. 2015 [cited 2015 Nov 11] Available from: www​.uptodate.com Subscription required.
10.
Doulton B. Pharmacologic management of adult breakthrough cancer pain. Can Fam Physician [Internet] 2014 Dec;60(12):1111–1119. [cited 2015 Nov 11]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC4264807. [PMC free article: PMC4264807] [PubMed: 25500600]
11.
Niscola P, Scaramucci L, Vischini G, Giovannini M, Ferrannini M, Massa P, et al. The Use of major analgesics in patients with renal dysfunction. Curr Drug Targets. 2010 Jun;11(6):752–758. [PubMed: 20041843]
12.
White C, Hardy J, Boyd A, Hall A. Subcutaneous sufentanil for palliative care patients in a hospital setting. Palliat Med. 2008 Jan;22(1):89–90. [PubMed: 18216082]
13.
Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage. 1997 May;13(5):254–261. [PubMed: 9185430]
14.
Maciejewski D. Sufentanil in anaesthesiology and intensive therapy. Anaesthesiol Intensive Ther. 2012 Jan;44(1):35–41. [PubMed: 23801512]
15.
Cancer Care Ontario's symptom management guides-to-practice: pain [Internet]. Toronto (ON): Cancer Care Ontario; 2010. [cited 2015 Nov 11]. Available from: https://www​.cancercare​.on.ca/CCO_DrugFormulary​/Pages/FileContent​.aspx?fileId=97481.
16.
Paix A, Coleman A, Lees J, Grigson J, Brooksbank M, Thorne D, et al. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain. 1995 Nov;63(2):263–269. [PubMed: 8628593]
17.
Kunz KM, Theisen JA, Schroeder ME. Severe episodic pain: management with sublingual sufentanil. J Pain Symptom Manage. 1993 May;8(4):189–190. [PubMed: 7963758]
18.
Jackson K, Keech J. Pilot dose finding study of intranasal sufentanil for breakthrough and incident pain cancer-associated pain [letter] J Pain Symptom Manage [Internet] 2002;23(6) [cited 2015 Nov 11]; Available from: http://intranasal​.net​/Peer%20Reviewed%20literature​/Jackson,%20IN​%20sufentanil%20in​%20breakthrough%20pain,​%20J%20Pain%20and​%20Symp%20Management%202002.pdf. [PubMed: 12067765]
19.
Passmore MJ. Sublingual sufentanil for incident pain and dementia-related response agitation. Int Psychogeriatr. 2011 Jun;23(5):844–846. [PubMed: 21349237]
20.
Hilliard N, Brown S, Mitchinson S. A case report of dexmedetomidine used to treat intractable pain and delirium in a tertiary palliative care unit. Palliat Med. 2015 Mar;29(3):278–281. [PubMed: 25467740]
21.
Guidelines & Protocols Advisory Committee. Palliative care for the patient with incurable cancer or advanced disease part 2: pain and symptom management pain management [Internet]. Victoria: British Columbia Ministry of Health; Sep 30, 2011. [cited 2015 Nov 11]. Available from: http://www2​.gov.bc.ca​/assets/gov/health/practitioner-pro​/bc-guidelines​/palliative2_pain.pdf.
22.
Hospice Palliative Care Program. Principles of opioid management: symptom guidelines [Internet]. Surrey (BC): Fraser Health; 2007. [cited 2015 Nov 11]. Available from: https://www​.fraserhealth​.ca/media/16FHSymptomGuidelinesOpioid.pdf.
23.
Dumont S, Jacobs P, Turcotte V, Turcotte S, Johnston G. Palliative care costs in Canada: a descriptive comparison of studies of urban and rural patients near end of life. Palliat Med. 2015 Jun:3. [PubMed: 26040484]
24.
Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol [Internet]. 2007;7:10. [cited 2015 Nov 11]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles​/PMC1810543/pdf/1471-2288-7-10.pdf. [PMC free article: PMC1810543] [PubMed: 17302989]
25.
Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012 Feb;13(2):e58–e68. [PubMed: 22300860]
26.
King S, Forbes K, Hanks GW, Ferro CJ, Chambers EJ. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med. 2011 Jul;25(5):525–552. [PubMed: 21708859]
27.
Bounes V, Barthelemy R, Diez O, Charpentier S, Montastruc JL, Ducasse JL. Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial. Ann Emerg Med. 2010 Nov;56(5):509–516. [PubMed: 20382445]
Copyright © 2015 Canadian Agency for Drugs and Technologies in Health.

Copyright: This report contains CADTH copyright material and may contain material in which a third party owns copyright. This report may be used for the purposes of research or private study only. It may not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner.

Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK333346
Contents

Views

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...